Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Compugen Ltd. (NasdaqNM:CGEN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs | Insider | Reports
Recent Events
July 25Conference call: Compugen Quarterly
Location
72 Pinchas Resen Street
Tel Aviv 69512, Israel
Phone: (609) 655-5105
Employees (last reported count): 168
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 50%
·Institutional: 13% (26% of float)
(14 institutions)
·Net Inst. Selling: 664.0K shares (+24.97%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Compugen Ltd. is engaged in the fields of computational genomics and proteomics. The Company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen's expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery, therapeutic and diagnostic. Compugen provides products and services to pharmaceutical, biotechnology and other life science organizations through corporate solutions and to individual life scientists through the LabOnWeb.com Website. In addition, the Company is commercializing the genes and proteins that are discovered through its drug discovery division.
More from Market Guide: Expanded Business Description

Financial Summary
Compugen Ltd. develops proprietary value added product and services, including ``web-enhanced'' products, and provides these products and services directly to individual life scientists worldwide. For the three months ended 3/31/01, revenues totalled $2.2 million, up from $859 thousand. Net loss decreased 11% to $3.6 million. Revenues reflect collaborations with Pfizer Global Research and Human Genome Sciences Inc. Earnings were offset by higher R&D and marketing expenses.

Recent Earnings Announcement
For the 3 months ended 06/30/2001, revenues were 2,907; after tax earnings were -3,950. (Preliminary; reported in thousands of dollars.)

More from Market Guide: Significant Developments

Officers[Insider Trade Data]

Position
Martin GerstelChairman
Eli MintzCEO, Pres
Mor AmitaiCEO
Lior Ma'ayanVP, COO
Simchon FaiglerVP, CTO
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CGENAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$3.125
Recent Price$4.12 
52-Week High
on 14-Sep-2000
$17.563
Daily Volume (3-month avg)87.5K
Daily Volume (10-day avg)205.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
26-Week Change-17.6%
26-Week Change
relative to S&P500
-10.3%
Share-Related Items
Market Capitalization$107.0M
Shares Outstanding26.0M
Float13.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq*)$3.44 
Earnings (ttm)-$3.25 
Earnings (mrq)-$0.15 
Sales (ttm)$0.50 
Cash (mrq*)$2.99 
Valuation Ratios
Price/Book (mrq*)1.20 
Price/EarningsN/A 
Price/Sales (ttm)8.29 
Income Statements
Sales (ttm)$9.80M
EBITDA (ttm*)-$17.7M
Income available to common (ttm)-$38.0M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter
(fully updated)
31-Mar-2001
Most recent quarter
(flash earnings)
30-June-2001
Management Effectiveness
Return on Assets (ttm)-17.19%
Return on Equity (ttm)-53.59%
Financial Strength
Current Ratio (mrq*)18.97 
Debt/Equity (mrq*)0 
Total Cash (mrq)$62.5M
Short Interest
As of 8-Aug-2001
Shares Short32.0K
Percent of Float0.2%
Shares Short
(Prior Month)
37.0K
Short Ratio0.37 
Daily Volume86.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001, except mrq*/ttm* items as of 31-Mar-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.